Skip to main content

Palliative Care and Endocrine Diseases

  • Living reference work entry
  • First Online:
Textbook of Palliative Care
  • 516 Accesses

Abstract

Palliative care in endocrine diseases is similar to palliative care in any other disease. The aim will be to reduce the symptoms, avoid short-term complications and improve or maintain the quality of life by minimal interference and with least inconvenience to the patient. Palliative care in diabetes mellitus aims at avoiding hypoglycemia and symptomatic hyperglycemia, and not necessarily achieving euglycemia or postponing/preventing chronic complications of diabetes. Palliative care in thyroid disorders aims to help the patient remain asymptomatic in both hypothyroidism and hyperthyroidism and not normalizing the TSH. Palliative care in all other endocrine diseases like Cushing’s disease, pheochromocytoma, pituitary tumor, insulinoma, and hyperparathyroidism is also mostly minimal medical intervention to alleviate symptoms and improve quality of life. Replacing endocrine deficiency as in Addisons disease, hypothyroidism, hypocalcemia due to hypoparathyroidism is important and similarly managed to any other endocrine deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1–G20.

    Article  CAS  PubMed  Google Scholar 

  • Boscaro M, Benato M, Mantero F. Effect of bromocriptine in pituitary-dependent Cushing’s syndrome. Clin. Endocrinol. (Oxf.). 1983;19(4):485–91.

    Article  CAS  Google Scholar 

  • Crane MG, Harris JJ. Effect of spironolactone in hypertensive patients. Am J Med Sci. 1970;260:311–30.

    Article  CAS  PubMed  Google Scholar 

  • End of life Diabetes care. Clinical care recommendations 2nd ed. 2013.

    Google Scholar 

  • Griebeler ML, Kearns AE, Ryu E, Thapa P, Hathcock MA, Melton LJ 3rd, et al. Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades. J Clin Endocrinol Metab. 2016;101(3):1166–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jeffcoate WJ, Rees LH, Tomlin S, Jones AE, Edwards CR, Besser GM. Metyrapone in long-term management of Cushing’s disease. Br Med J. 1977;2(6081):215–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper S, Kim W, Peeters P, Rosenthal MS, Sawka AM. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670–751.

    Article  PubMed  PubMed Central  Google Scholar 

  • Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing’s syndrome. J Clin Endocrinol Metab. 2001;86(9):4104–8.

    PubMed  CAS  Google Scholar 

  • Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353–61.

    Article  CAS  PubMed  Google Scholar 

  • Liu JK, Fleseriu M, Delashaw JB Jr, Ciric IS, Couldwell WT. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery. Neurosurg Focus. 2007;23(3):E8.

    Article  PubMed  Google Scholar 

  • Rizk A, Honegger J, Milian M, Psaras T. Treatment options in Cushing’s disease. Clin Med Insights Oncol. 2012;6:75–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rose BD. Diuretics. Kidney Int. 1991;39:336–52.

    Article  CAS  PubMed  Google Scholar 

  • Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D. Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients. Clin Endocrinol. 1991;35(4):347–52.

    Article  CAS  Google Scholar 

  • Sonino N, Boscaro M. Medical therapy for Cushing’s disease. Endocrinol Metab Clin N Am. 1999;28(1):211–22.

    Article  CAS  Google Scholar 

  • Ross DS, Burch B, Cooper David S, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343–421.

    Article  PubMed  Google Scholar 

  • Takats KI, Szabolcs I, Foldes J, Foldes I, Ferencz A, Rimanoczy E, Goth M, Dohan O, Kovacs L, Szilagyi G. The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses. Exp Clin Endocrinol Diabetes. 1999;107:70–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pallavi D Rao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Rao, P.D., Prasanna Kumar, K.M. (2018). Palliative Care and Endocrine Diseases. In: MacLeod, R., Van den Block, L. (eds) Textbook of Palliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-31738-0_112-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31738-0_112-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31738-0

  • Online ISBN: 978-3-319-31738-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics